DRUG · COUNSELLING NOTES
Tislelizumab
TEVIMBRA
Updated
New prescription
indication: _____. IV q3wk; report diarrhea, cough, rash; warned on allergies; serious/common AEs: immune colitis/pneumonitis, fatigue, rash; non-pharm: activity pacing, infection precautions.
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; IV q3wk; report diarrhea, cough, rash; warned on allergies; serious/common AEs: immune colitis/pneumonitis, fatigue, rash; non-pharm: activity pacing, infection precautions.